Health
Candidate vaccine by SII, Oxford varsity to join Ebola trial: WHO
TL;DR
- The candidate vaccine developed by the Oxford University and the Serum Institute of India is among the two such vaccines added to the ongoing Ebola clinical trials, according to a World Health Organisation (WHO) statement, making it the first addition of candidate vaccines to the
Short summary
Our full write-up is on its way. For the complete story, read the original report:
Nov 16, 2026 · Updated 11/17/2026, 2:31:18 AM · Reported with: Hindustan Times
Sources (1)
NRI Bytes writes its own articles from the reporting below.
Hindustan Times — Candidate vaccine by SII, Oxford varsity to join Ebola trial: WHO